Adrian Recinos III, Ph.D.
Assistant Professor
Adrian Recinos III, Ph.D.
Assistant Professor
Division of Endocrinology & Metabolism
Department of Internal Medicine
University of Texas Medical Branch
8.138 Medical Research Building
Galveston, TX 77555-1060
Phone: 409.772.1922
Fax: 409.772.8709
adrecino@utmb.edu
Personal Overview
Dr. Recinos is a molecular and vascular biologist interested in gene regulation and early inflammatory signaling events relative to the development of atherosclerosis and aneurysm formation. His studies involve cell culture and animal models with a view towards diagnostics and early therapeutic intervention. He is also interested in roles of components of the renin angiotensin system in exacerbating inflammatory processes in the vasculature. Dr. Recinos is also involved in the teaching of second year medical students in their Cardiovascular Pulmonary Course.
The UTMB Center for Global Health Education (CGHE) is dedicated to the training of tomorrow's global health work force to improve health for the people of Texas and around the world. Check out their website for more information on the global health programs and education going on in our department.
Featured Videos
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.
Currently available protocols are:- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.